MDR - PMCF Study for Taperloc Complete Stems

Recruiting now

Conditions studied: Hip Arthritis, Hip Disease, Hip Fractures, Hip Injuries, Hip Pain Chronic

In brief

The objective of this consecutive series PMCF study is to collect data confirming safety, performance, and clinical benefits of the Taperloc Complete stems when used for primary or revision total hip arthroplasty (implants) at 1,3,5,7 and 10-year follow-up\*. Since Taperloc Complete was introduced to the EU in 2010, all available retrospective data will be collected from each patient and a prospective aspect to the study will be necessary to reach the 10-year time point.

Key facts

Study ID
NCT04028687
Run by
Zimmer Biomet
People needed
820
Starts
2020-02-13
Expected to finish
2032-02-12
Last updated by the study team
2025-03-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.